Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01191827 · ClinicalTrials.gov registry record
fMRI Cholinergic Mechanisms in Schizophrenia
A clinical trial, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 40
- Enrollment target
NCT01191827: Completed study, sponsored by US Department of Veterans Affairs.
NCT01191827 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01191827 has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This study aims to determine how clozapine treatment improves neuronal measures of sensory gating in subjects with schizophrenia.
Primary Outcome
Neuronal response (blood oxygenation level dependent functional magnetic resonance imaging signal, relative to the global mean) during sensory gating. Sensory gating is defined as the process of filtering out unnecessary environmental stimuli.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-12 |
What the finished NCT01191827 record still lists
NCT01191827 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01191827 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01191827 about?
NCT01191827 is a clinical study titled "fMRI Cholinergic Mechanisms in Schizophrenia". This study aims to determine how clozapine treatment improves neuronal measures of sensory gating in subjects with schizophrenia.
What is the current status of trial NCT01191827?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2008-10. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01191827?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia